We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTRN icon
1326
Materion
MTRN
$5.88B
$551K 0.01%
8,965
+927
+12% +$46.9K
CVA
1327
DELISTED
Covanta Holding Corporation
CVA
$550K 0.01%
57,338
+10,007
+21% +$85.6K
PDCE
1328
DELISTED
PDC Energy, Inc.
PDCE
$548K 0.01%
44,039
PJT icon
1329
PJT Partners
PJT
$4.57B
$547K 0.01%
10,648
ONC
1330
BeOne Medicines Ltd
ONC
$40.3B
$546K 0.01%
2,900
+500
+21% +$81.4K
RRC icon
1331
Range Resources
RRC
$9.33B
$546K 0.01%
+96,973
New +$538K
ZUO
1332
DELISTED
Zuora, Inc.
ZUO
$545K 0.01%
42,713
+7,366
+21% +$82K
TNC icon
1333
Tennant Co
TNC
$1.15B
$544K 0.01%
8,362
CBZ icon
1334
CBIZ
CBZ
$2.96B
$541K 0.01%
22,559
+1,685
+8% +$38.2K
CORE
1335
DELISTED
Core Mark Holding Co., Inc.
CORE
$541K 0.01%
21,668
+2,709
+14% +$72.5K
OPI
1336
DELISTED
Office Properties Income Trust
OPI
$541K 0.01%
20,820
ICPT
1337
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$537K 0.01%
11,215
SWAV
1338
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$537K 0.01%
11,335
GLUU
1339
DELISTED
Glu Mobile Inc.
GLUU
$536K 0.01%
57,782
+8,279
+17% +$70.5K
SUPN icon
1340
Supernus Pharmaceuticals
SUPN
$2.74B
$534K 0.01%
22,494
NWBI icon
1341
Northwest Bancshares
NWBI
$2.31B
$534K 0.01%
52,239
+7,046
+16% +$72.6K
MAXR
1342
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$534K 0.01%
29,726
+4,494
+18% +$58.1K
FBC
1343
DELISTED
Flagstar Bancorp, Inc. New
FBC
$532K 0.01%
18,083
+2,939
+19% +$75.3K
AMSF icon
1344
AMERISAFE
AMSF
$504M
$531K 0.01%
8,690
LKFN icon
1345
Lakeland Financial Corp
LKFN
$1.56B
$530K 0.01%
11,384
SONO icon
1346
Sonos
SONO
$1.96B
$530K 0.01%
36,220
+4,058
+13% +$43.1K
DBRG icon
1347
DigitalBridge
DBRG
$2.94B
$529K 0.01%
+55,108
New +$478K
ICFI icon
1348
ICF International
ICFI
$1.6B
$529K 0.01%
8,158
AMKR icon
1349
Amkor Technology
AMKR
$14.3B
$528K 0.01%
42,920
+6,256
+17% +$64.6K
FBP icon
1350
First Bancorp
FBP
$4.49B
$527K 0.01%
94,227

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.